The pattern from the first three rounds of vaccination: declining vaccination rates

Introduction Vaccination rates for the COVID-19 vaccine have recently been stagnant worldwide. We aim to analyze the potential patterns of vaccination development from the first three doses to reveal the possible trends of the next round of vaccination and further explore the factors influencing vaccination in the selected populations. Methods On July 2022, a stratified multistage random sampling method in the survey was conducted to select 6,781 people from 4 provinces China, who were above the age of 18 years. Participants were divided into two groups based on whether they had a chronic disease. The data were run through Cochran-Armitage trend test and multivariable regression analyses. Results A total of 957 participants with chronic disease and 5,454 participants without chronic disease were included in this survey. Vaccination rates for the first, second and booster doses in chronic disease population were93.70% (95% CI: 92.19–95.27%), 91.12% (95%CI: 94.43–95.59%), and 83.18% (95%CI: 80.80–85.55%) respectively. By contrast, the first, second and booster vaccination rates for the general population were 98.02% (95% CI: 97.65–98.39%), 95.01% (95% CI: 94.43–95.59%) and 85.06% (95% CI: 84.11–86.00%) respectively. The widening gap in vaccination rates was observed as the number of vaccinations increases. Higher self-efficacy was a significant factor in promoting vaccination, which has been observed in all doses of vaccines. Higher education level, middle level physical activity and higher public prevention measures play a positive role in vaccination among the general population, while alcohol consumption acts as a significant positive factor in the chronic disease population (p < 0.05). Conclusion As the number of vaccinations increases, the trend of decreasing vaccination rate is becoming more pronounced. In future regular vaccinations, we may face low vaccination rates as the increasing number of infections and the fatigue associated with the prolonged outbreak hamper vaccination. Measures need to be found to counter this downward trend such as improving the self-efficacy of the population.

[1]  C. Napoli,et al.  The Effect of Preventive Measures and Vaccination against SARS-CoV-2 on the Infection Risk, Treatment, and Hospitalization: A Cross-Sectional Study of Algeria , 2022, Viruses.

[2]  A. Petrișor,et al.  The Importance of Behavioral and Native Factors on COVID-19 Infection and Severity: Insights from a Preliminary Cross-Sectional Study , 2022, Healthcare.

[3]  Liming Li,et al.  Evaluation of Immunogenicity and Safety of Vero Cell-Derived Inactivated COVID-19 Vaccine in Older Patients with Hypertension and Diabetes Mellitus , 2022, Vaccines.

[4]  Quanman Li,et al.  The association between lifestyle and COVID-19 vaccine hesitancy in China: A large-scale cross-sectional survey , 2022, Journal of Affective Disorders.

[5]  Cheng Yang,et al.  Changes of COVID-19 Knowledge, Attitudes, Practices and Vaccination Willingness Among Residents in Jinan, China , 2022, Frontiers in Public Health.

[6]  S. Gharbia,et al.  Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant , 2022, The New England journal of medicine.

[7]  Y. Maor,et al.  Waning effectiveness of the third dose of the BNT162b2 mRNA COVID-19 vaccine , 2022, Nature Communications.

[8]  M. Conner,et al.  Applying an extended protection motivation theory to predict Covid-19 vaccination intentions and uptake in 50–64 year olds in the UK , 2022, Social Science & Medicine.

[9]  S. Zeger,et al.  Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression , 2022, The Lancet.

[10]  Naiyang Shi,et al.  Using an extended protection motivation theory to explain vaccine hesitancy: a cross-sectional study among Chinese adults , 2022, Human vaccines & immunotherapeutics.

[11]  N. Andrews,et al.  Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines , 2022, The New England journal of medicine.

[12]  Jianzhou Yang,et al.  Reasons for COVID-19 Vaccine Hesitancy Among Chinese People Living With HIV/AIDS: Structural Equation Modeling Analysis , 2021, JMIR public health and surveillance.

[13]  Quanman Li,et al.  COVID-19 Vaccine Hesitancy Among Chinese Population: A Large-Scale National Study , 2021, Frontiers in Immunology.

[14]  Xinying Sun,et al.  Analysis of the Impact of Media Trust on the Public’s Motivation to Receive Future Vaccinations for COVID-19 Based on Protection Motivation Theory , 2021, Vaccines.

[15]  R. Anderson,et al.  Does infection with or vaccination against SARS-CoV-2 lead to lasting immunity? , 2021, The Lancet Respiratory Medicine.

[16]  P. Dormitzer,et al.  Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months , 2021, The New England journal of medicine.

[17]  William F. Fadel,et al.  Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings , 2021, The New England journal of medicine.

[18]  Colin Simpson,et al.  COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study , 2021, The Lancet Respiratory Medicine.

[19]  H. Fu,et al.  Predictors of Willingness to Receive the COVID-19 Vaccine after Emergency Use Authorization: The Role of Coping Appraisal , 2021, Vaccines.

[20]  J. Dai,et al.  Health Belief Model Perspective on the Control of COVID-19 Vaccine Hesitancy and the Promotion of Vaccination in China: Web-Based Cross-sectional Study , 2021, Journal of Medical Internet Research.

[21]  M. Sato,et al.  Clinical Characteristics and Survival Analysis in Frequent Alcohol Consumers With COVID-19 , 2021, Frontiers in Nutrition.

[22]  M. Ford,et al.  COVID-19 exposure and diagnosis among college student drinkers: links to alcohol use behavior, motives, and context , 2021, Translational behavioral medicine.

[23]  V. Narasimha,et al.  Effects of the COVID-19 pandemic and lockdown on alcohol use disorders and complications , 2021, Current opinion in psychiatry.

[24]  K. Freedberg,et al.  Clinical outcomes and cost-effectiveness of COVID-19 vaccination in South Africa , 2021, medRxiv.

[25]  Ami A. Shah,et al.  Risk Factors for Infection and Health Impacts of the Coronavirus Disease 2019 (COVID-19) Pandemic in People With Autoimmune Diseases , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  W. Low,et al.  Factors Affecting COVID-19 Vaccine Acceptance: An International Survey among Low- and Middle-Income Countries , 2021, Vaccines.

[27]  K. Hoffman,et al.  COVID-19 Vaccine Hesitancy and Acceptance Among Individuals With Cancer, Autoimmune Diseases, or Other Serious Comorbid Conditions: Cross-sectional, Internet-Based Survey , 2021, JMIR public health and surveillance.

[28]  S. Wong,et al.  Change of Willingness to Accept COVID-19 Vaccine and Reasons of Vaccine Hesitancy of Working People at Different Waves of Local Epidemic in Hong Kong, China: Repeated Cross-Sectional Surveys , 2021, Vaccines.

[29]  Naomi R. Waterlow,et al.  The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation , 2020, The Lancet Infectious Diseases.

[30]  Liyuan Tao,et al.  Influence of Cigarettes and Alcohol on the Severity and Death of COVID-19: A Multicenter Retrospective Study in Wuhan, China , 2020, Frontiers in Physiology.

[31]  R. A. Browne,et al.  Initial impact of the COVID-19 pandemic on physical activity and sedentary behavior in hypertensive older adults: An accelerometer-based analysis , 2020, Experimental Gerontology.

[32]  A. Gloster,et al.  The Role of Illness Perceptions, Coping, and Self-Efficacy on Adherence to Precautionary Measures for COVID-19 , 2020, International journal of environmental research and public health.

[33]  Huilan Xu,et al.  The impact of coronavirus disease (COVID-19) epidemic on lifestyle behaviors and their association with subjective wellbeing among the general population in the Mainland China: a cross-sectional study. , 2020, Journal of medical Internet research.

[34]  M. Antonelli,et al.  Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy. , 2020, JAMA internal medicine.

[35]  L. Leggio,et al.  New Challenges in Addiction Medicine: COVID-19 Infection in Patients With Alcohol and Substance Use Disorders-The Perfect Storm. , 2020, The American journal of psychiatry.

[36]  L. Barreiro,et al.  Herd Immunity: Understanding COVID-19 , 2020, Immunity.

[37]  Samuli Laato,et al.  Impact of Online Information on Self-Isolation Intention During the COVID-19 Pandemic: Cross-Sectional Study , 2020, Journal of medical Internet research.

[38]  Michael Roth,et al.  Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? , 2020, The Lancet Respiratory Medicine.

[39]  J. Kolls,et al.  Alcohol and Health Focus On: Alcohol and the Immune System Overview of the Human Immune System Alcohol and Health Alcohol and Health Alcohol and the Innate Immune Response Alcohol and Health , 2022 .